This research report focuses on the CRISPR and CRISPR-Associated (Cas) Genes Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.
TABLE OF CONTENTS
1 Report Business Overview
- 1.1 Study Scope
- 1.2 Market Analysis by Type
- 1.2.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
- 1.2.2 Genome Editing
- 1.2.3 Genetic engineering
- 1.2.4 gRNA Database/Gene Librar
- 1.2.5 CRISPR Plasmid
- 1.2.6 Human Stem Cells
- 1.2.7 Genetically Modified Organisms/Crops
- 1.2.8 Cell Line Engineering
- 1.3 Market by Application
- 1.3.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
- 1.3.2 Biotechnology Companies
- 1.3.3 Pharmaceutical Companies
- 1.3.4 Academic Institutes
- 1.3.5 Research and Development Institutes
- 1.4 Study Objectives
- 1.5 Years Considered
2 Global Growth Trends
- 2.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Perspective (2017-2028)
- 2.2 CRISPR and CRISPR-Associated (Cas) Genes Growth Trends by Region
- 2.2.1 CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region: 2017 VS 2021 VS 2028
- 2.2.2 CRISPR and CRISPR-Associated (Cas) Genes Historic Market Size by Region (2017-2022)
- 2.2.3 CRISPR and CRISPR-Associated (Cas) Genes Forecasted Market Size by Region (2023-2028)
- 2.3 CRISPR and CRISPR-Associated (Cas) Genes Market Dynamics
- 2.3.1 CRISPR and CRISPR-Associated (Cas) Genes Industry Trends
- 2.3.2 CRISPR and CRISPR-Associated (Cas) Genes Market Drivers
- 2.3.3 CRISPR and CRISPR-Associated (Cas) Genes Market Challenges
- 2.3.4 CRISPR and CRISPR-Associated (Cas) Genes Market Restraints
3 Competition Landscape by Key Players
- 3.1 Global Top CRISPR and CRISPR-Associated (Cas) Genes Players by Revenue
- 3.1.1 Global Top CRISPR and CRISPR-Associated (Cas) Genes Players by Revenue (2017-2022)
- 3.1.2 Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Players (2017-2022)
- 3.2 Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.3 Players Covered: Ranking by CRISPR and CRISPR-Associated (Cas) Genes Revenue
- 3.4 Global CRISPR and CRISPR-Associated (Cas) Genes Market Concentration Ratio
- 3.4.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Concentration Ratio (CR5 and HHI)
- 3.4.2 Global Top 10 and Top 5 Companies by CRISPR and CRISPR-Associated (Cas) Genes Revenue in 2021
- 3.5 CRISPR and CRISPR-Associated (Cas) Genes Key Players Head office and Area Served
- 3.6 Key Players CRISPR and CRISPR-Associated (Cas) Genes Product Solution and Service
- 3.7 Date of Enter into CRISPR and CRISPR-Associated (Cas) Genes Market
- 3.8 Mergers & Acquisitions, Expansion Plans
4 CRISPR and CRISPR-Associated (Cas) Genes Breakdown Data by Type
- 4.1 Global CRISPR and CRISPR-Associated (Cas) Genes Historic Market Size by Type (2017-2022)
- 4.2 Global CRISPR and CRISPR-Associated (Cas) Genes Forecasted Market Size by Type (2023-2028)
5 CRISPR and CRISPR-Associated (Cas) Genes Breakdown Data by Application
- 5.1 Global CRISPR and CRISPR-Associated (Cas) Genes Historic Market Size by Application (2017-2022)
- 5.2 Global CRISPR and CRISPR-Associated (Cas) Genes Forecasted Market Size by Application (2023-2028)
6 North America
- 6.1 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size (2017-2028)
- 6.2 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type
- 6.2.1 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2017-2022)
- 6.2.2 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2023-2028)
- 6.2.3 North America CRISPR and CRISPR-Associated (Cas) Genes Market Share by Type (2017-2028)
- 6.3 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application
- 6.3.1 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2017-2022)
- 6.3.2 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2023-2028)
- 6.3.3 North America CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application (2017-2028)
- 6.4 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country
- 6.4.1 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2017-2022)
- 6.4.2 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2023-2028)
- 6.4.3 U.S.
- 6.4.4 Canada
7 Europe
- 7.1 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size (2017-2028)
- 7.2 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type
- 7.2.1 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2017-2022)
- 7.2.2 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2023-2028)
- 7.2.3 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Share by Type (2017-2028)
- 7.3 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application
- 7.3.1 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2017-2022)
- 7.3.2 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2023-2028)
- 7.3.3 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application (2017-2028)
- 7.4 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country
- 7.4.1 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2017-2022)
- 7.4.2 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2023-2028)
- 7.4.3 Germany
- 7.4.4 France
- 7.4.5 U.K.
- 7.4.6 Italy
- 7.4.7 Russia
- 7.4.8 Nordic Countries
8 Asia-Pacific
- 8.1 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size (2017-2028)
- 8.2 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type
- 8.2.1 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2017-2022)
- 8.2.2 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2023-2028)
- 8.2.3 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Share by Type (2017-2028)
- 8.3 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application
- 8.3.1 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2017-2022)
- 8.3.2 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2023-2028)
- 8.3.3 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application (2017-2028)
- 8.4 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region
- 8.4.1 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region (2017-2022)
- 8.4.2 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region (2023-2028)
- 8.4.3 China
- 8.4.4 Japan
- 8.4.5 South Korea
- 8.4.6 Southeast Asia
- 8.4.7 India
- 8.4.8 Australia
9 Latin America
- 9.1 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size (2017-2028)
- 9.2 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type
- 9.2.1 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2017-2022)
- 9.2.2 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2023-2028)
- 9.2.3 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Share by Type (2017-2028)
- 9.3 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application
- 9.3.1 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2017-2022)
- 9.3.2 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2023-2028)
- 9.3.3 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application (2017-2028)
- 9.4 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country
- 9.4.1 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2017-2022)
- 9.4.2 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2023-2028)
- 9.4.3 Mexico
- 9.4.4 Brazil
10 Middle East & Africa
- 10.1 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size (2017-2028)
- 10.2 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type
- 10.2.1 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2017-2022)
- 10.2.2 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2023-2028)
- 10.2.3 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Share by Type (2017-2028)
- 10.3 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application
- 10.3.1 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2017-2022)
- 10.3.2 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2023-2028)
- 10.3.3 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application (2017-2028)
- 10.4 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country
- 10.4.1 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2017-2022)
- 10.4.2 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2023-2028)
- 10.4.3 Turkey
- 10.4.4 Saudi Arabia
- 10.4.5 UAE
11 Key Players Profiles
- 11.1 Thermo Fisher Scientific
- 11.1.1 Thermo Fisher Scientific Company Details
- 11.1.2 Thermo Fisher Scientific Business Overview
- 11.1.3 Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Introduction
- 11.1.4 Thermo Fisher Scientific Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
- 11.1.5 Thermo Fisher Scientific Recent Developments
- 11.2 Editas Medicine
- 11.2.1 Editas Medicine Company Details
- 11.2.2 Editas Medicine Business Overview
- 11.2.3 Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Introduction
- 11.2.4 Editas Medicine Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
- 11.2.5 Editas Medicine Recent Developments
- 11.3 Caribou Biosciences
- 11.3.1 Caribou Biosciences Company Details
- 11.3.2 Caribou Biosciences Business Overview
- 11.3.3 Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Introduction
- 11.3.4 Caribou Biosciences Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
- 11.3.5 Caribou Biosciences Recent Developments
- 11.4 CRISPR therapeutics
- 11.4.1 CRISPR therapeutics Company Details
- 11.4.2 CRISPR therapeutics Business Overview
- 11.4.3 CRISPR therapeutics CRISPR and CRISPR-Associated (Cas) Genes Introduction
- 11.4.4 CRISPR therapeutics Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
- 11.4.5 CRISPR therapeutics Recent Developments
- 11.5 Intellia therapeutics, Inc.
- 11.5.1 Intellia therapeutics, Inc. Company Details
- 11.5.2 Intellia therapeutics, Inc. Business Overview
- 11.5.3 Intellia therapeutics, Inc. CRISPR and CRISPR-Associated (Cas) Genes Introduction
- 11.5.4 Intellia therapeutics, Inc. Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
- 11.5.5 Intellia therapeutics, Inc. Recent Developments
- 11.6 Cellectis
- 11.6.1 Cellectis Company Details
- 11.6.2 Cellectis Business Overview
- 11.6.3 Cellectis CRISPR and CRISPR-Associated (Cas) Genes Introduction
- 11.6.4 Cellectis Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
- 11.6.5 Cellectis Recent Developments
- 11.7 Horizon Discovery Plc
- 11.7.1 Horizon Discovery Plc Company Details
- 11.7.2 Horizon Discovery Plc Business Overview
- 11.7.3 Horizon Discovery Plc CRISPR and CRISPR-Associated (Cas) Genes Introduction
- 11.7.4 Horizon Discovery Plc Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
- 11.7.5 Horizon Discovery Plc Recent Developments
- 11.8 Sigma Aldrich
- 11.8.1 Sigma Aldrich Company Details
- 11.8.2 Sigma Aldrich Business Overview
- 11.8.3 Sigma Aldrich CRISPR and CRISPR-Associated (Cas) Genes Introduction
- 11.8.4 Sigma Aldrich Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
- 11.8.5 Sigma Aldrich Recent Developments
- 11.9 Precision Biosciences
- 11.9.1 Precision Biosciences Company Details
- 11.9.2 Precision Biosciences Business Overview
- 11.9.3 Precision Biosciences CRISPR and CRISPR-Associated (Cas) Genes Introduction
- 11.9.4 Precision Biosciences Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
- 11.9.5 Precision Biosciences Recent Developments
- 11.10 Genscript
- 11.10.1 Genscript Company Details
- 11.10.2 Genscript Business Overview
- 11.10.3 Genscript CRISPR and CRISPR-Associated (Cas) Genes Introduction
- 11.10.4 Genscript Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
- 11.10.5 Genscript Recent Developments
- 11.11 Sangamo Biosciences Inc.
- 11.11.1 Sangamo Biosciences Inc. Company Details
- 11.11.2 Sangamo Biosciences Inc. Business Overview
- 11.11.3 Sangamo Biosciences Inc. CRISPR and CRISPR-Associated (Cas) Genes Introduction
- 11.11.4 Sangamo Biosciences Inc. Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
- 11.11.5 Sangamo Biosciences Inc. Recent Developments
- 11.12 Lonza Group Limited
- 11.12.1 Lonza Group Limited Company Details
- 11.12.2 Lonza Group Limited Business Overview
- 11.12.3 Lonza Group Limited CRISPR and CRISPR-Associated (Cas) Genes Introduction
- 11.12.4 Lonza Group Limited Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
- 11.12.5 Lonza Group Limited Recent Developments
- 11.13 Integrated DNA Technologies
- 11.13.1 Integrated DNA Technologies Company Details
- 11.13.2 Integrated DNA Technologies Business Overview
- 11.13.3 Integrated DNA Technologies CRISPR and CRISPR-Associated (Cas) Genes Introduction
- 11.13.4 Integrated DNA Technologies Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
- 11.13.5 Integrated DNA Technologies Recent Developments
- 11.14 New England Biolabs
- 11.14.1 New England Biolabs Company Details
- 11.14.2 New England Biolabs Business Overview
- 11.14.3 New England Biolabs CRISPR and CRISPR-Associated (Cas) Genes Introduction
- 11.14.4 New England Biolabs Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
- 11.14.5 New England Biolabs Recent Developments
- 11.15 Origene Technologies
- 11.15.1 Origene Technologies Company Details
- 11.15.2 Origene Technologies Business Overview
- 11.15.3 Origene Technologies CRISPR and CRISPR-Associated (Cas) Genes Introduction
- 11.15.4 Origene Technologies Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
- 11.15.5 Origene Technologies Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.2 Data Source
- 13.2 Author Details
- 13.3 Disclaimer